Table 1 Demographic Characteristics of the Participants (N =300)

Age (years)

6.8

0.9 ^ns

 13

20 (10.0)

6 (12.0)

8 (16.0)

 14

28 (14.0)

7 (14.0)

7 (14.0)

 15

37 (18.5)

11 (22.0)

10 (20.0)

 16

33 (16.5)

7 (14.0)

8 (16.0)

 17

39 (19.5)

10 (20.0)

6 (12.0)

 18

43 (21.5)

9 (18.0)

11 (22.0)

Sex

0.3

0.9 ^ns

 Male

108 (54.0)

28 (56.0)

26 (52.0)

 Female

92 (46.0)

22 (44.0)

24 (48.0)

Parents’ Educational Attainment

1.0

1.0 ^ns

 Primary school or below

32 (16.0)

6 (12.0)

7 (14.0)

 Lower secondary school

63 (31.5)

15 (30.0)

14 (28.0)

 Upper secondary school

71 (35.5)

19 (38.0)

20 (40.0)

 Tertiary education

34 (17.0)

10 (20.0)

9 (18.0)

Diagnosis

6.5

0.3 ^ns

 Leukemia

91 (45.5)

19 (38.0)

-

 Lymphoma

57 (28.5)

12 (24.0)

-

 Brain tumor

33 (16.5)

8 (16.0)

-

 Osteosarcoma

9 (4.5)

4 (8.0)

-

 Kidney tumor

4 (2.0)

3 (6.0)

-

 Germ-cell tumor

6 (3.0)

4 (8.0)

-

Treatment received

3.6

1.0^ns

 Surgery

23 (11.5)

5 (10.0)

-

 Chemotherapy

90 (45.0)

22 (44.0)

-

 Bone Marrow Transplant

22 (11.0)

5 (10.0)

-

 Mixed method:

  Chemotherapy and radiotherapy

12 (6.0)

3 (6.0)

-

  Surgery and chemotherapy

19 (9.5)

5 (10.0)

-

  Chemotherapy and bone marrow transplantation

23 (11.5)

7 (14.0)

-

  Radiotherapy and surgery

11 (5.5)

3 (6.0)

-

Time since treatment completed

 6 - 12 months

39 (19.5)

-

-

 13 – 24 months

37 (18.5)

-

-

 25 – 36 months

33 (16.5)

-

-

 37 – 48 months

31 (15.5)

-

-

 48 – 60 months

33 (16.5)

-

-

 >60 months

27 (13.5)

-

-